|
[1]
|
Haymart, M.R. (2021) Progress and Challenges in Thyroid Cancer Management. Endocrine Practice, 27, 1260-1263. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Chen, D.W., Lang, B.H.H., Mcleod, D.S.A., Newbold, K. and Haymart, M.R. (2023) Thyroid Cancer. The Lancet, 401, 1531-1544. [Google Scholar] [CrossRef]
|
|
[3]
|
Haugen, B.R., Alexander, E.K., Bible, K.C., et al. (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thy-roid Cancer. Thyroid, 26, 1-133. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Pizzato, M., Li, M., Vignat, J., et al. (2022) The Epidemiological Land-scape of Thyroid Cancer Worldwide: GLOBOCAN Estimates for Incidence and Mortality Rates in 2020. The Lancet Diabetes and Endocrinology, 10, 264-272. [Google Scholar] [CrossRef]
|
|
[5]
|
Bauermeister, A., Mannochio-Russo, H., Costa-Lotufo, L.V., Jarmusch, A.K. and Dorrestein, P.C. (2022) Mass Spectrometry-Based Metabolomics in Microbiome Investigations. Nature Reviews Microbiology, 20, 143-160. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Anwardeen, N.R., Diboun, I., Mokrab, Y., Althani, A.A. and Elrayess, M.A. (2023) Statistical Methods and Resources for Biomarker Discovery Using Metabolomics. BMC Bioin-formatics, 24, Article No. 250. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Chacko, S., Haseeb, Y.B. and Haseeb, S. (2022) Metabolomics Work Flow and Analytics in Systems Biology. Current Molecular Medicine, 22, 870-881. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Chen, X. and Yu, D. (2019) Metabolomics Study of Oral Cancers. Metabolomics, 15, Article No. 22. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ganesan, R., Yoon, S.J. and Suk, K.T. (2022) Microbiome and Metabolomics in Liver Cancer: Scientific Technology. International Journal of Molecular Sciences, 24, Article 537. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Xiao, Y., Ma, D., Yang, Y.S., et al. (2022) Comprehensive Metabo-lomics Expands Precision Medicine for Triple-Negative Breast Cancer. Cell Research, 32, 477-490. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Li, M., Dal Maso, L. and Vaccarella, S. (2020) Global Trends in Thyroid Cancer Incidence and the Impact of Overdiagnosis. The Lancet Diabetes and Endocrinology, 8, 468-470. [Google Scholar] [CrossRef]
|
|
[12]
|
Kodama, M. and Nakayama, K.I. (2020) A Second War-burg-Like Effect in Cancer Metabolism: The Metabolic Shift of Glutamine-Derived Nitrogen: A Shift in Gluta-mine-Derived Nitrogen Metabolism from Glutaminolysis to De Novo Nucleotide Biosynthesis Contributes to Malignant Evolution of Cancer. BioEssays, 42, e2000169. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Arguello, R.J., Combes, A.J., Char, R., et al. (2020) SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution. Cell Metabolism, 32, 1063-1075. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Feng, J., Li, J., Wu, L., et al. (2020) Emerging Roles and the Reg-ulation of Aerobic Glycolysis in Hepatocellular Carcinoma. Journal of Experimental & Clinical Cancer Research, 39, Article No. 126. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Cao, L., Wu, J., Qu, X., et al. (2020) Glycometabolic Rear-rangements—Aerobic Glycolysis in Pancreatic Cancer: Causes, Characteristics and Clinical Applications. Journal of Ex-perimental & Clinical Cancer Research, 39, Article No. 267. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Miccoli, P., Torregrossa, L., Shintu, L., et al. (2012) Metabo-lomics Approach to Thyroid Nodules: A High-Resolution Magic-Angle Spinning Nuclear Magnetic Resonance-Based Study. Surgery, 152, 1118-1124. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Bian, X., Liu, R., Meng, Y., et al. (2021) Lipid Metabolism and Cancer. Journal of Experimental Medicine, 218, e20201606. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Li, D. and Li, Y. (2020) The Interaction between Ferroptosis and Lipid Metabolism in Cancer. Signal Transduction and Targeted Therapy, 5, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Arslanbaeva, L., Tosi, G., Ravazzolo, M., et al. (2022) UBIAD1 and CoQ10 Protect Melanoma Cells from Lipid Peroxidation-Mediated Cell Death. Redox Biology, 51, Article ID: 102272. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Lin, F., Li, X., Wang, X., et al. (2022) Stanniocalcin 1 Promotes Metastasis, Lipid Metabolism and Cisplatin Chemoresistance via the FOXC2/ITGB6 Signaling Axis in Ovarian Cancer. Journal of Experimental & Clinical Cancer Research, 41, Article No. 129. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Ippolito, L., Comito, G., Parri, M., et al. (2022) Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate Cancer. Cancer Research, 82, 1267-1282. [Google Scholar] [CrossRef]
|
|
[22]
|
Zhu, Y., Gu, L., Lin, X., et al. (2020) Dynamic Regulation of ME1 Phosphorylation and Acetylation Affects Lipid Metabolism and Colorectal Tumorigenesis. Molecular Cell, 77, 138-149. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Zhang, H., Yi, J.K., Huang, H., et al. (2021) Rhein Suppresses Colorectal Cancer Cell Growth by Inhibiting the mTOR Pathway in vitro and in vivo. Cancers, 13, Article 2176. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Wang, S., Fu, J.L., Hao, H.F., et al. (2021) Metabolic Repro-gramming by Traditional Chinese Medicine and Its Role in Effective Cancer Therapy. Pharmacological Research, 170, Article ID: 105728. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Zhang, H., Ma, L., Kim, E., et al. (2023) Rhein Induces Oral Can-cer Cell Apoptosis and ROS via Suppresse AKT/mTOR Signaling Pathway in vitro and in vivo. International Journal of Molecular Sciences, 24, Article 8507. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Gupta, S., Sahu, D., Bomalaski, J.S., et al. (2018) Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20. Endocrine Pathology, 29, 236-241. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Matos, A., Carvalho, M., Bicho, M. and Ribeiro, R. (2021) Argi-nine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression. Nutrients, 13, Article 4503. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Yuan, J.B., Gu, L., Chen, L., Yin, Y. And Fan, B.Y. (2021) Annexin A8 Regulated by lncRNA-TUG1/miR-140-3p Axis Promotes Bladder Cancer Progression and Metastasis. Mo-lecular Therapy-Oncolytics, 22, 36-51. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Johnson, C.H., Dejea, C.M., Edler, D., et al. (2015) Metabolism Links Bacterial Biofilms and Colon Carcinogenesis. Cell Metabolism, 21, 891-897. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Wikoff, W.R., Hanash, S., Defelice, B., et al. (2015) Diacetyl-spermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance with Pro-Surfactant Protein B. Journal of Clinical Oncology, 33, 3880-3886. [Google Scholar] [CrossRef]
|
|
[31]
|
Umemori, Y., Ohe, Y., Kuribayashi, K., et al. (2010) Evaluating the Utility of N1, N12-Diacetylspermine and N1, N8-Diacetylspermidine in Urine as Tumor Markers for Breast and Col-orectal Cancers. Clinica Chimica Acta, 411, 1894-1899. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Zhu, Y., Piao, C., Zhang, Z., et al. (2022) The Potential Role of c-MYC and Polyamine Metabolism in Multiple Drug Resistance in Bladder Cancer Investigated by Metabonomics. Genomics, 114, 125-137.
|
|
[33]
|
Geng, P., Qin, W. and Xu, G. (2021) Proline Metabolism in Cancer. Amino Acids, 53, 1769-1777. [Google Scholar] [CrossRef] [PubMed]
|